Use of SGLT2 Inhibitors in Patients With HF With and Without Type 2 Diabetes An Endocrinologist's Perspective

被引：0
|
作者：
Butler, Javed [1 ,2 ,3 ]
Pessah-Pollack, Rachel [4 ]
机构：
[1] Baylor Scott & White Res Inst, 3434 Live Oak St,Suite 501, Dallas, TX 75204 USA
[2] Baylor Scott & White Hlth, Dallas, TX USA
[3] Univ Mississippi, Sch Med, Jackson, MS USA
[4] NYU, Sch Med, New York, NY USA
来源：
JACC-HEART FAILURE | 2024年 / 12卷 / 06期
关键词：
heart failure; SGLT2; inhibitors; type; 2; diabetes;
D O I：
10.1016/j.jchf.2024.01.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S4 / S6
页数：3
相关论文
共 50 条
  • [21] Severe ketoacidosis after taking SGLT2 inhibitors in 2 patients without diabetes
    Andres, Ulrike
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (02) : 98 - 99
  • [22] GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
    Neves, Joao Sergio
    Borges-Canha, Marta
    Vasques-Novoa, Francisco
    Green, Jennifer B.
    Leiter, Lawrence A.
    Granger, Christopher B.
    Carvalho, Davide
    Leite-Moreira, Adelino
    Hernandez, Adrian F.
    Del Prato, Stefano
    McMurray, John J. V.
    Md, Joao Pedro Ferreira
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (06) : 517 - 525
  • [23] SGLT2 inhibitors in Type 1 diabetes: is this the future?
    Herring, R.
    Russell-Jones, D. L.
    DIABETIC MEDICINE, 2018, 35 (12) : 1642 - 1643
  • [24] Effects of SGLT2 Inhibitors on Gut Microbiota in Japanese Patients with Type 2 Diabetes
    Kusunoki, Masataka
    Hisano, Fumiya
    Matsuda, Shin-Ichi
    Miyata, Tetsuro
    DIABETES, 2023, 72
  • [25] The effect of SGLT2 inhibitors on drugnaive obese type 2 diabetes mellitus patients
    Chikazawa, Shinji
    Matsuhashi, Yuki
    Tando, Yusuke
    Daimon, Makoto
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S103 - S103
  • [26] Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus
    Ribola, F. A.
    Cancado, F. B.
    Schoueri, J. H. M.
    De Toni, V. F.
    Medeiros, V. H. R.
    Feder, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) : 199 - 211
  • [27] The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes
    Tosaki, Takahiro
    Kamiya, Hideki
    Kato, Yoshiro
    Kondo, Masaki
    Nakamura, Jiro
    DIABETES, 2015, 64 : A154 - A155
  • [28] Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes
    Huang, Yen-Min
    Chen, Wan-Ming
    Jao, An-Tzu
    Chen, Mingchih
    Shia, Ben-Chang
    Wu, Szu-Yuan
    DIABETES & METABOLISM, 2024, 50 (01)
  • [29] Cardiovascular outcomes with SGLT2 inhibitors in patients with atrial fibrillation and type 2 diabetes
    Kim, S.
    Cho, Y.
    Suh, Y.
    Seo, D.
    Kim, Y.
    Shin, S-H
    DIABETOLOGIA, 2024, 67 : S342 - S342
  • [30] The extent of use of SGLT2 inhibitors in patients with type 2 diabetes in clinical practice: A study from India
    Gokalani, Rutul
    Panchal, Dharmendra
    Saboo, Banshi
    Zinzuwadia, Padmanabh
    Patel, Dishank
    Chaudhury, Rupam
    Chavda, Vipul
    Phatak, Sanjeev
    Prasad, Renuka
    Dariya, S. S.
    Shnakar, Arun
    Prajapati, Ajay
    Chudasama, Dipak
    Patel, Nitesh
    JOURNAL OF DIABETOLOGY, 2021, 12 (03) : 305 - 309
12345